Janni W, Nitz U, Rack BK. et al.
Pooled analysis of two randomized phase III trials (PlanB/SuccessC) comparing six cycles of docetaxel and cyclophosphamide to sequential anthracycline taxane chemotherapy in patients with intermediate and high risk HER2-negative early breast cancer (n = 5,923).
J Clin Oncol 2018;
36: 522 . doi:510.1200/JCO.2018.1236.1215_suppl.1522
Download Bibliographical Data